Lv3
325 积分 2020-11-07 加入
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
21小时前
待确认
Special Population: lean MASH
1天前
已关闭
Non-invasive tests: Establishing efficacy for metabolic dysfunction–associated steatohepatitis beyond the biopsy—Current perspectives from the Division of Hepatology and Nutrition, US Food and Drug Administration
1天前
已完结
Current status and future trends of the global burden of MASLD
1天前
已完结
Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
14天前
已完结
Clinical Efficacy and Safety of the Intra-articular Injection of Autologous Adipose-Derived Mesenchymal Stem Cells for Knee Osteoarthritis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
14天前
已完结
Three-dimensional texture analyses of multi-quantitative relaxation time maps for evaluating cartilage repair with the treatment of allogeneic human adipose-derived mesenchymal progenitor cells
14天前
已完结
Impact of MASLD and MetALD on clinical outcomes: A meta‐analysis of preliminary evidence
14天前
已完结
Clinical phenotypes, molecular endotypes and theratypes in OA therapeutic development
19天前
已完结
Osteoarthritis
24天前
已完结
皖公网安备34019202002308
